IFP Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21K Sell
1,961
-581
-23% -$6.5K ﹤0.01% 2928
2026
Q2
$27.9K Buy
2,542
+1,467
+136% +$13.8K ﹤0.01% 2754
2026
Q1
$8.74K Sell
1,075
-1,323
-55% -$11.4K ﹤0.01% 3216
2025
Q4
$24.9K Buy
2,398
+1,284
+115% +$13.5K ﹤0.01% 2607
2025
Q3
$9.9K Buy
1,114
+875
+366% +$6.24K ﹤0.01% 2912
2025
Q2
$1.38K Buy
+239
New +$1.46K ﹤0.01% 4072
2025
Q1
– Sell
-9
Closed -$78 – 4501
2024
Q4
$78 Buy
+9
New +$130 ﹤0.01% 4120
2020
Q4
– Sell
-2,628
Closed -$92.3K – 3026
2020
Q3
$81K Buy
+2,628
New +$58K ﹤0.01% 1088
2019
Q1
– Sell
-14
Closed – – 2928
2018
Q4
$0 Hold
14
– – ﹤0.01% 3717
2018
Q3
$0 Buy
+14
New +$268 ﹤0.01% 3925

Other funds holding KURA

IFP Advisors's KURA Position: Q3 2026 in Review

IFP Advisors reduced its Kura Oncology (KURA) stake by 23% in Q3 2026, selling an estimated $6.5K and leaving 1,961 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

IFP Advisors first reported a position in KURA in Q3 2018 and has held it in 10 quarters since. The position peaked at $81K in Q3 2020. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • IFP Advisors held 1,961 shares of Kura Oncology worth $21K as of Q3 2026.
  • IFP Advisors sold 581 Kura Oncology shares in Q3 2026, an estimated $6.5K.
  • Kura Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2928 holding.
  • IFP Advisors first reported a position in Kura Oncology in Q3 2018 and has held it in 10 quarters since.
  • IFP Advisors's Kura Oncology position peaked at $81K in Q3 2020.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.